Treatment for USE in a Mass Casualty Event Where Thrombocytopenia or Platelet Loss IS a Major Concern
Contract Overview
Contract Amount: $773,879,007 ($773.9M)
Contractor: Amgen USA Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2022-09-30
End Date: 2032-09-29
Official Description: TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.